SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MLAB

Mesa Laboratories Inc /Co/ (NASDAQ:MLAB)

US · Delayed Price · Currency is USD
Healthcare · Medical - Specialties
$127.93-$5.48 (-4.11%)
 
Market cap
$719M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 29, 1984
Market Cap$719.03M+64.6%
Revenue (ttm)$251.32M+2.5%
Net Income$6.67M+524.0%
EPS$1.14+456.3%
Shares Out5.62M
PE Ratio108.42
Forward PE10.69
Dividend$0.64(0.50%)
Ex-Dividend DateNov 30, 2026
Volume76,014
Open$131.33
Previous Close$133.41
Day's Range$126.73 - $133.93
52-Week Range$70.19 - $144.35
Beta1.08
AnalystsHold
Price Target$110.00(-14.02%)
Earnings DateFeb 3, 2027

About MLAB

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Address
12100 West Sixth Avenue, Lakewood, CO, 80228, US
Market Cap
719 million
Employees
717
Industrial Classification
Medical - Specialties

What Are Insiders Doing?

Open-market buy / sell balanceBalanced
Sold
$1.57M
Bought
$1.16M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $110.00 (-14.0%)

1 firm rating MLAB in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Strong
From MLAB’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-4.11%
5 Days
-8.04%
1 Month
-0.91%
6 Months
+17.76%
1 Year
+64.56%

$MLAB stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in MLAB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by MLAB's directors and management

Net Shares Purchased by Insiders−9k−5k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

MLAB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

MLAB Revenue by Segment or Geography

MLAB's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New MLAB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to MLAB from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in MLAB

IWMiShares Russell 2000 ETF$18.57M
VTIVanguard Morningstar Total Stock Market ETF$16.97M
VXFVanguard Extended Market ETF$8.01M
FESMFidelity Enhanced Small Cap ETF$7.61M
IWOiShares Russell 2000 Growth ETF$6.80M
DFATDimensional - US Targeted Value ETF$5.01M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from MLAB’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
65.78
Analyst Ratings
32% of score
81
News & Sentiment
20% of score
72

News check: Q2 2027 earnings beat with margin expansion and inaugural full-year guidance signal positive momentum and management confidence.

Recent Insider Activity

Buys
3
Sells
7
Buy Value
$1.16M
Distinct Buyers
3

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

KDVDKeeley Dividend ETF2.18%
OASCOneAscent Enhanced Small and Mid Cap ETF1.16%
JSMLJanus Henderson Small Cap Growth Alpha ETF1.14%
AIMSAcuitas Small Cap Active ETF0.98%
SAWSAAM Sawgrass U.S. Small Cap Quality Growth ETF0.97%
BUYOKraneShares Man Buyout Beta Index ETF0.39%
RUSCRussell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETF0.35%
GNOMGlobal X - Genomics & Biotechnology ETF0.30%
PQSGPGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF0.19%
SMLVState Street SPDR US Small Cap Low Volatility Index ETF0.18%
DESWisdomTree U.S. SmallCap Dividend Fund0.15%
DMRSDeltaShares S&P 600 Managed Risk ETF0.15%

Weight is the stock’s share of each fund’s holdings.